ReadOns.com | Discover New Blogs Daily

Novavax and mRNA vaccines – Approach, production, storage, and more

Vaccines are biological preparations aimed at providing active, acquired immunity to an infectious or malignant disease. In the past few years, mRNA and Novavax vaccines have been administered to control the spread of the coronavirus. mRNA and Novavax vaccines have garnered significant attention for their efficacy and rapid development. This article attempts to shed light on the Novavax vaccine and highlights the key differences that set it apart from mRNA vaccines.

Novavax’s approach
Novavax’s COVID-19 vaccine, known as NVX-CoV2373 or simply Novavax, is built upon a different platform than the mRNA vaccine. It belongs to a category of vaccines called protein subunits. The fundamental principle of protein subunit vaccines is to introduce a harmless part of the virus into the body to stimulate an immune response without causing the infection.

In the case of Novavax, the vaccine is formulated using a small piece of the spike protein found on the surface of the SARS-CoV-2 virus, which is responsible for facilitating entry into human cells. This spike protein is produced in the lab and serves as the antigen, which triggers an immune response. The immune system recognizes this foreign protein as a potential threat and develops antibodies against it. These antibodies are then ready to neutralize the spike protein if the person is later exposed to the actual virus.

mRNA’s approach
mRNA vaccines utilize a unique approach. Instead of using a piece of the actual virus protein, they rely on a small piece of genetic material called messenger RNA (mRNA). This mRNA carries instructions to cells to produce a harmless spike protein similar to the one found on the SARS-CoV-2 virus. The immune system recognizes this spike protein as foreign and generates an immune response, just as it does with the Novavax vaccine. The critical difference is that the mRNA vaccines directly introduce genetic instructions, while Novavax uses a pre-made protein.

Storage and distribution
One of the most significant differences between Novavax and mRNA vaccines is their storage and distribution requirements. Some mRNA vaccines need to be stored at extremely low temperatures, requiring ultra-cold storage at around -70°C (-94°F). Other mRNA options are kept at sub-zero temperatures but below the 70°C threshold. In contrast, Novavax’s protein subunit vaccine is far more forgiving in terms of storage. It can be stored at standard refrigerator temperatures of 2°C to 8°C (36°F to 46°F), which makes it more practical for distribution and administration in various settings, especially in regions with limited access to advanced cold storage infrastructure.

Efficacy and effectiveness
Novavax and mRNA vaccines have demonstrated impressive efficacy in healthcare trials, but their effectiveness may vary against specific virus variants. mRNA vaccines have shown high effectiveness against the original strain of the virus and several variants. However, their efficacy may decrease against some new variants that have emerged. Novavax, while effective against the original strain, has shown good results against certain variants, such as the Alpha and Beta variants. Its protein-based approach may offer some advantages, as the immune system is exposed to the entire spike protein, potentially generating a broader immune response.

Production and scalability
Another crucial difference between Novavax and mRNA vaccines is their production process and scalability. mRNA vaccines are relatively quick to develop and adapt, as they rely on synthesizing the genetic instructions for the spike protein. This process could be modified relatively easily to target new variants. Novavax’s production process is somewhat more complex, as it involves growing the spike protein in culture and then purifying it for vaccine formulation. This process may take more time and resources. However, protein subunit vaccines like Novavax can be produced on a larger scale with well-established manufacturing techniques.

Safety profiles
mRNA vaccines and Novavax have shown favorable safety profiles in trials and in real-world usage. One may experience side effects such as pain in the area where the vaccine was introduced, fatigue, and a mild fever. But these are short-term and indicative of the body’s immune response. Serious adverse events are exceedingly rare for both vaccine types. It’s worth noting that vaccine safety is continually monitored, and any emerging concerns are thoroughly investigated. However, the overall safety record of both Novavax and mRNA vaccines remains positive.

Administration
The Novavax vaccine is authorized for emergency use to provide a two-dose primary series for individuals 12 years of age and older. It is also approved for emergency use as a first booster dose for the following individuals at least six months after completion of primary vaccination with an authorized or approved COVID-19 vaccine. This applies to the following:

Individuals 18 years of age and older for whom an FDA-authorized mRNA bivalent COVID-19 booster vaccine is not accessible or clinically appropriate
Individuals 18 years of age and older who elect to receive the Novavax COVID-19 Vaccine, Adjuvanted, as they would otherwise not receive a booster dose of a COVID-19 vaccine

The FDA also amended and approved the mRNA vaccines for emergency use by various individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals six months of age and older, including for an additional dose or doses for certain populations. Those who desire the latest and most precise details of the vaccine dosage and requirements should consult with an expert or the nearest healthcare center.

To conclude
In the quest to curb the spread of the virus, multiple vaccine options are available, each with its own unique characteristics. Novavax’s protein subunit vaccine distinguishes itself from the mRNA vaccines by using pre-made spike proteins rather than genetic instructions. Additionally, Novavax’s storage and distribution requirements are less stringent, making it more accessible in resource-limited settings.
Ultimately, the choice between these vaccines depends on various factors, including availability, storage capabilities, and individual preferences. However, the common goal remains the same: achieving widespread vaccination to achieve herd immunity and end the global pandemic.
One should also consult with an expert or their doctor, who is usually the best individual to check with about Novavax and the mRNA vaccine.

Source

1. https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/novavax-covid-19-vaccine-adjuvanted
2. https://www.genome.gov/genetics-glossary/messenger-rna

3. https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/novavax-covid-19-vaccine-adjuvanted

4. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines

Popular Reads

11 useful tips for anxiety management

Nearly 84% of participants in a particular mental health survey were said to have some form of anxiety. The severity of symptoms did vary from person to person, but the fact remains that we live in a world where almost everything is a potential trigger for anxiety. And living in denial about having a psychological trigger only worsens the problem. Luckily, it is possible to manage anxiety by following the suggestions recommended by experts. Identify the triggers Anxiety is mainly triggered due to an event or episode where one finds themselves in a difficult position. It could be something that puts a person out of their comfort zone. Doctors advise people to identify these triggers and avoid them. Any comment, action, or situation that did not work out in favor triggers anxiety. So, make a list of such events and instances and ignore them the next time something happens related to that event. At the same time, try to remain positive as it can help strengthen the mind to manage anxiety better. Keep busy Distraction is one of the simplest ways to prevent a panic or anxiety attack. You can perform simple chores or indulge in a favorite task to stay physically and mentally occupied for a few hours. When the mind is occupied, there is hardly any scope for negative thoughts to trigger unnecessary overthinking. Some creative activities to boost cognitive performance include taking a walk, painting, drawing, listening to music, meditating, praying, and reading. You can opt for any of these to stay busy. Try mindfulness techniques Deep breathing and mindfulness techniques have helped thousands overcome their fear or anxiety time and again. Focused deep breathing is a method where one inhales for four counts and exhales for the same duration; this is practiced for minutes. It helps lower heart rate, which, in turn, calms the mind and body.

Atrial fibrillation – Causes, symptoms, and management tips

The human heart is susceptible to several health complications, including atrial fibrillation (AFib). The condition is the most common type of treated heart arrhythmia, which is a term describing when the heart beats unusually slowly, fast, or irregularly. AFib is estimated to affect between 2.7 million to 6.1 million individuals in the country. An individual with the complication experiences irregular beating in the heart’s upper chambers, affecting blood flow, leading to health complications. Causes Irregularities in the structure of the heart are the most common cause of atrial fibrillation. Sometimes people may develop the condition without any known heart damage or problems. Risk factors like age may also contribute to the development of atrial fibrillation. Other potential causes of the phenomenon include a heart attack, sick sinus syndrome – issues with the heart’s natural pacemaker, coronary artery disease, congenital heart defect – A heart defect that an individual might be born with, high blood pressure, lung diseases, heart valve problems, use of stimulants, including certain prescriptions and caffeine, physical stress caused due to pneumonia, other illnesses, and also surgery, sleep apnea, overactive thyroid (hyperthyroidism), metabolic imbalances, viral infections, and complications due to earlier heart surgery. Symptoms A person who develops atrial fibrillation may not notice symptoms, and the condition is detected only after a physical examination. But some people experience signs and symptoms before a diagnosis. A few common symptoms of AFib include being unable to exercise to one’s full potential, feelings of weakness, throbbing pain in the chest, lightheadedness, shortness of breath, dizziness, palpitations and sensations of a fast, fluttering, or pounding heartbeat, and feeling extremely fatigued. Therefore, the symptoms of atrial fibrillation differ from one person to the other. Occasional symptoms (paroxysmal atrial fibrillation) Here, a person may experience something that lasts from a few minutes to a couple of hours.

Macular degeneration – Types, causes, and remedies

Macular degeneration is a condition that affects a person’s vision and develops as people age. This progressive eye disorder involves the deterioration of the macula, which is a part of the eye’s retina. It is a leading cause of vision loss in older adults and may develop in one or both eyes. This condition is of two main types – dry and wet. Read further to learn about the disorder, its causes, and its types. Dry macular degeneration People are more likely to have dry macular degeneration than wet form. It is also less severe and develops when tiny yellow protein deposits under the macula. These deposits dry and thin the macula, causing gradual central vision loss while the peripheral vision remains intact. In the advanced stages, the dry form can progress to the wet form. People with dry macular degeneration need to test their eyes daily at home using an Amsler grid. One must consult a health expert immediately if any vision changes are observed. Wet macular degeneration In this condition, the blood vessels grow beneath the retina and macula and cause blood and fluid to leak into the retina. This build-up of fluid results in scarring, leading to permanent loss of central vision. The wet form can cause a sudden change in eyesight resulting in a severe loss of centralized vision when left untreated. People with wet macular degeneration may require repeated treatments. Symptoms Macular degeneration may not cause any symptoms during the early stages. However, as the condition progresses, it can cause distortion and blurry vision. It can result in difficulty reading, driving, and identifying colors. Macular degeneration occurs mainly in people aged over 50. Blurred vision Dark, blurry areas appear in the center of the vision, leading to increased blurriness in reading printed words. Visual distortion The person may experience visual distortions, such as straight lines that look wavy or crooked, and objects may appear distorted.